StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 4.6
Power Rank trend -> Falling
03/27/2025 16:10:00 EST
STERIS plc (STE)
Industry: Medical Devices
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, STE has been trading in a range between $232.74 and $219.26 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
The AI powered stock chart is in a Red zone currently. We would avoid this stock.
Upside / Downside Potential
STERIS plc $STE entered a Red zone 5 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $248.2625, a potential upside of 11.3% from the recent price of 223.06. The stock is trading 10.71% (potential upside) below its 52 week high of $246.95 and 13.88 % (potential downside) above its 52 week low of $195.87 - based on the recent price.
Company Summary
STERIS plc provides infection prevention products and services worldwide It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.
News
| Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy' Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with management confident in further recovery despite challenges from rising labor costs and raw material inflation. For FY25, Steris guides for 6% revenue growth and 3.1% adjusted EPS growth, with significant contributions expected from Healthcare Products and AST segments. Source: Seeking Alpha Sat, 22 Mar 2025 07:22:30 -0400 Sentiment: Positive |
| Steris (STE) Up 3% Since Last Earnings Report: Can It Continue? Steris (STE) reported earnings 30 days ago. What's next for the stock? Source: Zacks Investment Research Fri, 07 Mar 2025 12:36:21 -0500 Sentiment: Positive |
| Steris (STE) International Revenue in Focus: Trends and Expectations Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects. Source: Zacks Investment Research Mon, 10 Feb 2025 10:21:43 -0500 Sentiment: Neutral |
| STERIS plc (STE) Q3 2025 Earnings Call Transcript STERIS plc (NYSE:STE ) Q3 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Julie Winter – Investor Relations Mike Tokich – Senior Vice President and Chief Financial Officer Dan Carestio – President and Chief Executive Officer Conference Call Participants Jacob Johnson – Stephens Brett Fishbin – KeyBanc Michael Polark – Wolfe Research Jason Bednar – Piper Sandler Patrick Wood – Morgan Stanley Mike Matson – Needham & Company Dave Turkaly – Citizens Operator Good day, and welcome to the STERIS plc Third Quarter 2025 Conference Call. All participants will be in a listen-only mode. Source: Seeking Alpha Thu, 06 Feb 2025 14:52:37 -0500 Sentiment: Neutral |
| STE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket STERIS' third-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. The lowered revenue guidance for fiscal 2025 is concerning. Source: Zacks Investment Research Thu, 06 Feb 2025 10:51:30 -0500 Sentiment: Positive |
Technicals 52 Week Hi: 246.9508 52 Week Low: 195.8732 Beta: 0.92 50 Day MA: 221.6684 200 Day MA: 224.1343 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0.238 Qtr Revenue Growth YOY: 0.056 Forward PE: 24.7525 Trailing PE: 35.8195